Rosen DG, Yang G, Liu G, Mercado-Uribe I, Chang B, Xiao XS, et al. Ovarian cancer: pathology, biology, and disease models. Frontiers in bioscience : a journal and virtual library. 2009;14:2089-102.Rosen DG, Yang G, Liu G, Mercado-Uribe I, Chang B, Xiao XS, Zheng J, Xue FX...
Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int. J. Clin. Oncol. 14, 383-391.Mandai M, Yamaguchi K, ... I Konishi - 《International Journal of Clinical Oncology》 被引量: 31发表: 2009年 Clinical management of endometriosis. Endometriosis is a relati...
Ovarian surface epithelium: biology, endocrinology, and pathology. The epithelial ovarian carcinomas, which make up more than 85% of human ovarian cancer, arise in the ovarian surface epithelium (OSE). The etiology and ear... A Nelly,AST Wong,Choi Kyung-Chul,... - 《Endocrine Reviews》 被...
摘要: Pathology of malignant ovarian tumors General Classification of Ovarian Cancers All ovarian tumors, including the malignant forms (ovarian cancer), are classified into four main categories: Epithelial...DOI: 10.1007/978-3-642-27841-9_6925-8 年份: 2014 ...
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. The accepted view of ovarian carcinogenesis is that carcinoma begins in the ovary, undergoes progressive "dedifferentiation" from a well to a poorly differ... RJ Kurman,S Iem - 《Internationa...
Ovarian cancer development and metastasis. The biology of ovarian carcinoma differs from that of hematogenously metastasizing tumors because ovarian cancer cells primarily disseminate within the per... E Lengyel - 《American Journal of Pathology》 被引量: 891发表: 2010年 Membrane type 1-matrix metallo...
New insights into ovarian cancer pathology Malignant epithelial tumors (carcinomas) are the most common ovarian cancers and also the most lethal gynecological malignancies. Based on histopathology a... J. Prat* - 《Annals of Oncology》 被引量: 283发表: 2012年 Pathology, genetics and cell biology...
Tumor markers are widely used in pathology not only for diagnostic purposes but also to assess the prognosis and to predict the treatment of the tumor. Because tumor marker levels may change over time, it is important to get a better understanding of the molecular changes during tumor progression...
Ovarian cancer: Epidemiology, biology, and prognostic factors advances in molecular genetics have found mutations in the BRCA1 and BRCA2 tumor suppressor genes responsible for the majority of hereditary ovarian cancer... CH Holschneider,JS Berek - 《Seminars in Surgical Oncology》 被引量: 920发表...
Conclusions Genomic analyses have accelerated the identification of relevant biomarkers and extended our understanding of the molecular biology of ovarian cancer. This in turn, will hopefully lead to a paradigm shift from empirical, uniform treatment to a more rational, personalized treatment of ovarian ...